Drug for treating otitis media

A technology of otitis media and medicine, which is applied in the field of medicine for the treatment of otitis media, can solve the problems of insignificant treatment effect, large side effects, high treatment cost, etc., and achieve the effect of low treatment cost, small side effects and good curative effect

Inactive Publication Date: 2013-11-13
TIANJIN PACIFIC PHARMA
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The purpose of the present invention is to overcome the shortcomings of inconspicuous therapeutic effect, large side effects and high treatment cost, and provide a medicine for treating otitis media

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] A medicine for treating otitis media, comprising: honeysuckle, forsythia, andrographis paniculata, gentian, calamus calamus and licorice, wherein the weight-number ratio of each component is:

[0030] Honeysuckle 9 servings

[0031] Forsythia 8 servings

[0032] Andrographis 10 servings

[0033] Gentian 5 parts

[0034] Shichangpu 8 servings

[0035] Licorice 9 parts

Embodiment 2

[0037] A medicine for treating otitis media, comprising: honeysuckle, forsythia, andrographis paniculata, gentian, calamus calamus and licorice, wherein the weight-number ratio of each component is:

[0038] Honeysuckle 10 servings

[0039] Forsythia 8 servings

[0040] Andrographis 10 servings

[0041] Gentian 7 servings

[0042] Shichangpu 11 servings

[0043] Licorice 8 parts

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a drug for treating otitis media. The drug comprises the following components in parts by weight: 8-12 parts of honeysuckle, 6-10 parts of weeping forsythia capsule, 6-11 parts of common andrographis herb, 4-9 parts of gentian, 7-15 parts of grassleaf sweetflag rhizome and 8-12 parts of liquorice. The drug has the advantages and positive effects of good curative effects, small side effects and low treatment cost.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a medicine for treating otitis media. Background technique [0002] Otitis media is an inflammation of the middle ear, usually caused by pathogenic heat invading the ear orifice. Acute to chronic, and even affect hearing. The current method for treating otitis media is mostly western medicine antibiotics, but there are shortcomings such as ineffective effect, high drug price, and large side effects. Contents of the invention [0003] The purpose of the invention is to overcome the shortcomings of inconspicuous therapeutic effect, large side effects and high treatment cost, and provide a medicine for treating otitis media. [0004] Technical scheme of the present invention is: [0005] A medicine for treating otitis media, comprising: honeysuckle, forsythia, andrographis paniculata, gentian, calamus calamus and licorice, wherein the weight-number ratio of each component is: ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/888A61P27/16
Inventor 宋德成邸克莱刘彩田王磊
Owner TIANJIN PACIFIC PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products